S&P/ASX 200 Index (ASX: XJO) shares are ripping on Monday, up 2% to 8,885.5 points as earnings season continues.
On The Bull today, Jabin Hallihan from Family Financial Solutions reveals his ratings on three of the biggest names on the ASX 200.
One is a buy, one is a hold, and one is a sell.
Let's take a look.
Image source: Getty Images
CSL Ltd (ASX: CSL)
CSL shares are $180.87 apiece, up 0.2% on Monday and down 31% over the past six months.
The CSL share price plunged after the company released its FY25 report last August.
So, it will be interesting to see what happens when CSL releases its next significant earnings report on Wednesday.
Meantime, Hallihan has a buy rating on the ASX 200 healthcare sector's largest company.
Hallihan says:
The share price has fallen from $271.32 on August 18, 2025 to trade at $181.48 on February 5, 2026.
Our fair value is $295 a share.
Short term earnings noise obscures a high quality plasma franchise with structural demand growth.
In a bull market, valuation normalisation and quality should deliver strong upside moving forward.
Wesfarmers Ltd (ASX: WES)
The Wesfarmers share price is $86.28, up 1.5% today and down 2.6% over the past six months.
Wesfarmers is the consumer discretionary sector's largest stock by market capitalisation.
It owns Bunnings, Kmart, Officeworks, Priceline Pharmacy, Soul Pattinson Chemist, and others.
Hallihan rates the ASX 200 retail conglomerate a sell.
… in our view, the stock remains significantly overvalued, with optimism already priced in.
The stock was recently trading on a lofty price/earnings ratio above 32 times, so it's exposed to a correction on signs of any weakness.
We would be inclined to trim holdings and re-invest the proceeds in stocks offering better value.
Wesfarmers will release its 1H FY26 results next Thursday, 19 February.
Woolworths Group Ltd (ASX: WOW)
Woolworths shares are $31.73 apiece, up 0.9% on Monday and down 0.8% over the past six months.
Hallihan has a hold rating on the ASX 200 consumer staples sector's largest company.
He comments:
The share price of this supermarket giant is slowly recovering after releasing its first quarter sales results in fiscal year 2026 to the market on October 29, 2025.
While Woolworths acknowledged first quarter sales were below aspirations, group sales of $18.5 billion were up 2.7 per cent on the prior corresponding period.
Australian food sales were up 2.1 per cent.
Competitive pricing and cost pressures limit near term upside, but scale advantages remain intact.
The company's defensive characteristics appeal in an economy of higher interest rates.
Woolworths will reveal its 1H FY26 results on Wednesday, 25 February.
